Patients with MetS may also exhibit micro-albuminuria, endothelial dysfunction and a pro-inflammatory and pro-thrombotic state, with increased circulating C-reactive protein (CRP), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). This evidence concerns the gene CRP and metabolic syndrome.